GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Merck Tbk (GREY:PMKIF) » Definitions » EV-to-FCF

PT Merck Tbk (PT Merck Tbk) EV-to-FCF : 11.80 (As of May. 29, 2024)


View and export this data going back to 2012. Start your Free Trial

What is PT Merck Tbk EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, PT Merck Tbk's Enterprise Value is $100.75 Mil. PT Merck Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was $8.54 Mil. Therefore, PT Merck Tbk's EV-to-FCF for today is 11.80.

The historical rank and industry rank for PT Merck Tbk's EV-to-FCF or its related term are showing as below:

PMKIF' s EV-to-FCF Range Over the Past 10 Years
Min: -711.88   Med: 14.61   Max: 222.51
Current: 12.34

During the past 13 years, the highest EV-to-FCF of PT Merck Tbk was 222.51. The lowest was -711.88. And the median was 14.61.

PMKIF's EV-to-FCF is ranked better than
72.16% of 528 companies
in the Drug Manufacturers industry
Industry Median: 23.61 vs PMKIF: 12.34

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-29), PT Merck Tbk's stock price is $2.14. PT Merck Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.003. Therefore, PT Merck Tbk's PE Ratio for today is 713.33.


PT Merck Tbk EV-to-FCF Historical Data

The historical data trend for PT Merck Tbk's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Merck Tbk EV-to-FCF Chart

PT Merck Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.63 33.45 11.66 21.90 9.18

PT Merck Tbk Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.73 14.30 9.65 9.18 12.27

Competitive Comparison of PT Merck Tbk's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, PT Merck Tbk's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Merck Tbk's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Merck Tbk's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where PT Merck Tbk's EV-to-FCF falls into.



PT Merck Tbk EV-to-FCF Calculation

PT Merck Tbk's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=100.745/8.54
=11.80

PT Merck Tbk's current Enterprise Value is $100.75 Mil.
PT Merck Tbk's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT Merck Tbk  (GREY:PMKIF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

PT Merck Tbk's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.14/0.003
=713.33

PT Merck Tbk's share price for today is $2.14.
PT Merck Tbk's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.003.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


PT Merck Tbk EV-to-FCF Related Terms

Thank you for viewing the detailed overview of PT Merck Tbk's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Merck Tbk (PT Merck Tbk) Business Description

Traded in Other Exchanges
Address
Jalan T.B. Simatupang No. 8, Pasar Rebo, Jakarta Timur, IDN, 13760
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia. The company operates in three segments: Biopharma, Consumer Health, and Others. The company offers pharmaceutical and biological prescription medicines to treat cancer, multiple sclerosis, infertility, growth disorders, and cardiovascular and metabolic diseases, as well as chronic diseases.

PT Merck Tbk (PT Merck Tbk) Headlines

No Headlines